Used in research as a potent and selective dopamine reuptake inhibitor, this compound is primarily investigated for its potential in treating central nervous system disorders such as depression, attention deficit hyperactivity disorder (ADHD), and fatigue. It shows high affinity for the dopamine transporter (DAT), enhancing dopamine signaling in neural pathways associated with motivation and cognition. Due to its structural properties, it serves as a lead compound in developing analogs with improved pharmacokinetic profiles. It is not approved for clinical use but remains valuable in neuropharmacological studies exploring dopaminergic transmission and novel psychostimulant therapies.